The pharmaceutical world is witnessing a remarkable shift in diabetes treatment with the emergence of GLP-1 patches. These patches offer a potentially more convenient alternative to subcutaneous administrations of GLP-1 receptor agonists, reducing the requirement of daily needle pricks. The approach delivers the medication directly through the s… Read More